Celldex Therapeutics reported $326.2M in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agenus AGEN:US USD -61278000 40.89M
Amgen AMGN:US USD 3.66B 8M
Aptinyx Inc APTX:US USD 48.79M 13.31M
Biocept BIOC:US USD 27.52M 4.94M
Celldex Therapeutics CLDX:US USD 326.2M 19.21M
Cytrx CYTR:US USD 3.28M 1.5M
Glaxosmithkline GSK:US GBP 10.6B 1.45B
Immunogen IMGN:US USD 155.83M 22.18M
Merrimack Pharmaceuticals MACK:US USD 13.19M 425K
Nektar Therapeutics NKTR:US USD 366.64M 45.58M
Newlink Genetics NLNK:US USD 59.58M 8.12M
Northwest Biotherapeutics NWBO:US USD -95104000 3.44M
Rigel Pharmaceuticals RIGL:US USD -13616000 33.45M
Roche Holding ROG:VX 27.99B 2.8B
Seattle Genetics SGEN:US USD 2.8B 17.99M